With a working knowledge of regulatory requirements and a strong understanding of life science, Xin Tao works closely with clients in the food and drug industry to navigate the evolving federal and state regulatory environments and also communicate with agency officials and develop innovative regulatory strategies.
Xin's background in life science (biochemistry and molecular genetics) assists him in his science-based food and drug law practices. Xin advises clients on food and drug law with a particular focus on food ingredients, dietary supplements, and food and pharmaceutical packaging materials.
Xin has helped numerous food, dietary supplement, and pharmaceutical companies evaluate the need for marketing approval from the U.S. Food and Drug Administration (FDA) and the U.S. Department of Agriculture (USDA). He also pursues clearance or pre-market approval when necessary and responds to FDA enforcement activities. Xin has advised numerous companies on issues relating to the advertising and promoting of products including the Federal Trade Commission (FTC)'s claim substantiation standards. Xin also has vast experience with FDA and USDA due diligence investigations for companies subject to takeover or merger activity. He assists with finalizing deals and identifies regulatory deficiencies. He is increasingly expanding his knowledge of California's Proposition 65 as it pertains to his clients.
Obtained FDA and FSIS authorization for a novel food contact substance used for collecting and removing gases and liquid impurities during the meat aging process.
Helped companies respond effectively and on time to Form FDA 483 observations and Warning Letters challenging the manufacturing and labeling practices.
Developed legal strategies in helping companies establishing compliance with Proposition 65 warning for BPA.
Developed legal and scientific support for the advertising of novel food and dietary supplement products under FTC's claim substantiation standards.
Latest thinking and events
Sponsorships and Speaking Engagements
17 September 2016